• In 2015, China became the second largest pharmaceutical market in the world.
  • Demand for pharmaceuticals, including generics, is expected to grow due to the demand created by China’s 1.3 billion residents.
  • U.S. FDA-approved medicines are favored, and may command a price premium in China
  • In 2015, the Chinese FDA (CFDA) implemented several new guidelines to
    • facilitate the approval of U.S. FDA approved pharmaceutical products in China
    • ensure quality of pharmaceutical products used by its citizens